Findings

What do systematic reviews say?

1,782 questions · 1,852 findings · 128 reviews · Effective Practice and Organisation of Care

Sort:Best matchNewestHighest certainty Download CSV

No studies found 557 · 30.1%GRADE not reported 53 · 2.9%Very low 446 · 24.1%Low 476 · 25.7%Moderate 255 · 13.8%High 65 · 3.5%

Intervention not reported

Costs per patient or prescription

1 finding from 1 review

Pharmaceutical policies: effects of financial incentives for prescribers 2015 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
Very low

Intervention not reported

Total costs

1 finding from 1 review

Pharmaceutical policies: effects of financial incentives for prescribers 2015 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
Very low

Intervention not reported

Healthcare utilisation (referral to outpatient specialists)

1 finding from 1 review

Pharmaceutical policies: effects of financial incentives for prescribers 2015 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
Very low

Intervention not reported

Health outcomes

The review found no eligible studies for this question.

1 finding from 1 review

Pharmaceutical policies: effects of financial incentives for prescribers 2015 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Intervention not reported

Drug use

1 finding from 1 review

Pharmaceutical policies: effects of financial incentives for prescribers 2015 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
Very low

Intervention not reported

Costs

The review found no eligible studies for this question.

1 finding from 1 review

Pharmaceutical policies: effects of financial incentives for prescribers 2015 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Intervention not reported

Medicine use · vulnerable and general populations

The review found no eligible studies for this question.

1 finding from 1 review

Pharmaceutical policies: effects of cap and co‐payment on rational use of medicines 2015 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Intervention not reported

Overall healthcare utilisation · vulnerable and general populations

The review found no eligible studies for this question.

1 finding from 1 review

Pharmaceutical policies: effects of cap and co‐payment on rational use of medicines 2015 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Intervention not reported

Emergency department and hospitalisation · vulnerable and general populations

1 finding from 1 review

Pharmaceutical policies: effects of cap and co‐payment on rational use of medicines 2015 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
Very low

Intervention not reported

Outpatient care · vulnerable and general populations

1 finding from 1 review

Pharmaceutical policies: effects of cap and co‐payment on rational use of medicines 2015 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
Very low

Intervention not reported

Health outcomes · vulnerable and general populations

The review found no eligible studies for this question.

1 finding from 1 review

Pharmaceutical policies: effects of cap and co‐payment on rational use of medicines 2015 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Intervention not reported

Medicine use · vulnerable population: senior 65 years of age or older

The review found no eligible studies for this question.

1 finding from 1 review

Pharmaceutical policies: effects of cap and co‐payment on rational use of medicines 2015 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Intervention not reported

Overall use of medicines · vulnerable population: senior 65 years of age or older

1 finding from 1 review

Pharmaceutical policies: effects of cap and co‐payment on rational use of medicines 2015 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
Low

Intervention not reported

Use of medicines for symptomatic conditions · vulnerable population: senior 65 years of age or older

1 finding from 1 review

Pharmaceutical policies: effects of cap and co‐payment on rational use of medicines 2015 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
Low

Intervention not reported

Use of medicines for asymptomatic conditions · vulnerable population: senior 65 years of age or older

1 finding from 1 review

Pharmaceutical policies: effects of cap and co‐payment on rational use of medicines 2015 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
Low

Intervention not reported

Cost · vulnerable population: senior 65 years of age or older

The review found no eligible studies for this question.

1 finding from 1 review

Pharmaceutical policies: effects of cap and co‐payment on rational use of medicines 2015 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Intervention not reported

Patient perspective · vulnerable population: senior 65 years of age or older

1 finding from 1 review

Pharmaceutical policies: effects of cap and co‐payment on rational use of medicines 2015 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
Low

Intervention not reported

Overall use of medicines · vulnerable and general populations

1 finding from 1 review

Pharmaceutical policies: effects of cap and co‐payment on rational use of medicines 2015 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
Low

Intervention not reported

Insurer perspective (expenditures on medicines) · vulnerable population: senior 65 years of age or older

The review found no eligible studies for this question.

1 finding from 1 review

Pharmaceutical policies: effects of cap and co‐payment on rational use of medicines 2015 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Intervention not reported

Insurer perspective (expenditures on health care) · vulnerable population: senior 65 years of age or older

The review found no eligible studies for this question.

1 finding from 1 review

Pharmaceutical policies: effects of cap and co‐payment on rational use of medicines 2015 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found